Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Barometers extend winning streak for 3rd session; Nifty settles above 24,250 mark
The Nifty settled above the 24,250 mark. Realty, IT and pharma shares advanced, while PSU bank, media and auto shares declined.
Sensex Today Ends 261 Points Higher | Nifty Above 24,250 | Bharti Airtel & Sun Pharma Top Gainers - Equitymaster
Sensex Today Ends 261 Points Higher | Nifty Above 24,250 | Bharti Airtel & Sun Pharma Top GainersEquitymaster
Sensex Today Ends 261 Points Higher | Nifty Above 24,250 | Bharti Airtel & Sun Pharma Top Gainers - Equitymaster
Sensex Today Ends 261 Points Higher | Nifty Above 24,250 | Bharti Airtel & Sun Pharma Top GainersEquitymaster
Sun Pharma Share Price Live Updates: Sun Pharma achieves a notable 10.47% return in three months
IBM to set up one of India's first quantum computers in Amaravati by September 2026
Amaravati is set to become a major hub for quantum computing in India, with IBM announcing plans to install one of its advanced quantum systems there by September 2026. This move, driven by India's strong talent pool, aims to unlock significant commercial advantages across various sectors. The initiative aligns with Andhra Pradesh's vision to establish itself as a leading quantum technology center, fostering research and innovation.
Sun Pharma Share Price Live Updates: Sun Pharma's Strong 3-Month Returns
Mankind Pharma partners Denovo Sciences for AI-led drug discovery
Mankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This collaboration aims to significantly cut down early research timelines, enhance the quality of potential drug candidates, and ensure only the most promising ones advance. By combining Mankind Pharma's R&D prowess with Denovo's AI platform, the companies expect to bring effective and accessible treatments to patients faster, marking a significant step in innovation-driven research.
Elara Securities turns bullish on banks, power, IT after market correction
Bino Pathiparampil, Head of Research, Elara Securities (India), says Indian markets are nearing a medium-term bottom after a prolonged correction and is turning constructive on banks, power, select new-age companies, IT and real estate. While pharma remains a defensive bet, he expects margin pressure to limit near-term outperformance. He also believes IT stocks are gradually pricing in AI-led headwinds, making it a good time to start accumulating quality names.
Sun Pharma Share Price Live Updates: Sun Pharma Reports Negative Weekly Returns
Coal India to invest ₹1,900 crore in R&D by FY30
Coal India Ltd is set to invest nearly ₹1,900 crore in R&D by FY2030 to boost mine productivity and cut emissions. The company is focusing on cleaner coal technologies and alternative energy sources, with its R&D spending significantly increasing this fiscal. New initiatives include a National Centre for Coal and Energy Research and collaborations with international partners for advanced projects.
Nifty 50 index slides below 23,950 level; auto shares outperform as Maruti Suzuki leads charge
The key equity benchmarks continued to trade below the flat line in afternoon trade. The Nifty 50 index traded below the 23,950 level. Auto, pharma and realty index advanced while IT, banks and FMCG stocks declined.
